217 related articles for article (PubMed ID: 15905070)
21. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
22. PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome.
Terrin A; Monterisi S; Stangherlin A; Zoccarato A; Koschinski A; Surdo NC; Mongillo M; Sawa A; Jordanides NE; Mountford JC; Zaccolo M
J Cell Biol; 2012 Aug; 198(4):607-21. PubMed ID: 22908311
[TBL] [Abstract][Full Text] [Related]
23. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics.
Willoughby D; Wong W; Schaack J; Scott JD; Cooper DM
EMBO J; 2006 May; 25(10):2051-61. PubMed ID: 16642035
[TBL] [Abstract][Full Text] [Related]
24. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
Ang KL; Antoni FA
J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
[TBL] [Abstract][Full Text] [Related]
26. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
Carlisle Michel JJ; Dodge KL; Wong W; Mayer NC; Langeberg LK; Scott JD
Biochem J; 2004 Aug; 381(Pt 3):587-92. PubMed ID: 15182229
[TBL] [Abstract][Full Text] [Related]
27. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells.
Naro F; Sette C; Vicini E; De Arcangelis V; Grange M; Conti M; Lagarde M; Molinaro M; Adamo S; Némoz G
Mol Biol Cell; 1999 Dec; 10(12):4355-67. PubMed ID: 10588663
[TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.
Li X; Huston E; Lynch MJ; Houslay MD; Baillie GS
Biochem J; 2006 Mar; 394(Pt 2):427-35. PubMed ID: 16356165
[TBL] [Abstract][Full Text] [Related]
29. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.
Dodge KL; Khouangsathiene S; Kapiloff MS; Mouton R; Hill EV; Houslay MD; Langeberg LK; Scott JD
EMBO J; 2001 Apr; 20(8):1921-30. PubMed ID: 11296225
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
[TBL] [Abstract][Full Text] [Related]
31. A RSK(y) relationship with promiscuous PKA.
Houslay MD
Sci STKE; 2006 Aug; 2006(349):pe32. PubMed ID: 16926362
[TBL] [Abstract][Full Text] [Related]
32. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases.
Baillie GS; MacKenzie SJ; McPhee I; Houslay MD
Br J Pharmacol; 2000 Oct; 131(4):811-9. PubMed ID: 11030732
[TBL] [Abstract][Full Text] [Related]
33. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
[TBL] [Abstract][Full Text] [Related]
34. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
[TBL] [Abstract][Full Text] [Related]
35. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform.
Shepherd M; McSorley T; Olsen AE; Johnston LA; Thomson NC; Baillie GS; Houslay MD; Bolger GB
Biochem J; 2003 Mar; 370(Pt 2):429-38. PubMed ID: 12441002
[TBL] [Abstract][Full Text] [Related]
37. Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation.
Haworth RS; Cuello F; Avkiran M
Basic Res Cardiol; 2011 Jan; 106(1):51-63. PubMed ID: 20725733
[TBL] [Abstract][Full Text] [Related]
38. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
39. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
40. Phosphodiesterase 4 interacts with the 5-HT4(b) receptor to regulate cAMP signaling.
Weninger S; Van Craenenbroeck K; Cameron RT; Vandeput F; Movsesian MA; Baillie GS; Lefebvre RA
Cell Signal; 2014 Nov; 26(11):2573-82. PubMed ID: 25101859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
